Basilea Pharmaceutica AG

SIX:BSLN.SW

44.35 (CHF) • At close September 18, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CHF.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002
Omzet 157.634147.765148.122127.629134.381132.555101.52165.98452.82542.49940.95158.33666.15115.55526.82811.9747.8987.18430.4950.2870.3790.204
Kosten van de omzet 26.79426.80324.07224.05418.868125.24164.0853.79660.07554.37753.3494.3982.36601.630.279000000
Brutowinst 130.84120.962124.05103.575115.5137.31437.44112.188-7.25-11.878-12.39953.93763.784115.55525.19811.6957.8987.18430.4950.2870.3790.204
Brutowinstmarge 0.830.8190.8370.8120.860.0550.3690.185-0.137-0.279-0.3030.9250.96410.9390.977111111
Onderzoek- en ontwikkelingskosten 77.85273.80493.15797.41102.662105.14255.35549.04967.27570.07753.34958.86370.04856.04777.24197.408115.69582.80172.39568.92150.03457.21
Algemene en administratieve kosten 33.78330.81529.72129.422031.40953.13956.07754.23530.08721.31345.92351.68579.43769.15966.79328.98612.5278.947.0846.2295.816
Verkoop- en marketingkosten 030.81529.72129.42230.05131.40953.1390.20.30.121.31345.9230000000000
Verkoop-, algemene en administratieve kosten 33.78330.81529.72129.42230.05130.47151.57756.07754.23530.08721.31345.92351.68579.43769.15966.79328.98612.5278.947.0846.2295.816
Overige kosten -1.9350.81-1.236000.938000000-0.699-127.61500.117-0.313-0.2140-1.073-0.964-0.618
Bedrijfskosten 111.635104.619122.878126.832132.71331.94649.81456.76354.27630.00620.887104.785121.0347.869146.399164.201144.36895.11481.33576.00556.26263.026
Bedrijfsresultaat 19.20516.3431.172-23.257-17.2-23.157-14.136-43.889-61.485-41.83-33.286-50.848-57.25107.686-121.201-152.506-136.469-87.931-50.84-75.718-55.883-62.822
Bedrijfsresultaat ratio 0.1220.1110.008-0.182-0.128-0.175-0.139-0.665-1.164-0.984-0.813-0.872-0.8650.932-4.518-12.736-17.278-12.24-1.667-264.099-147.362-307.429
Totaal overige inkomsten en kosten netto -8.744-4.241-7.9668.59-5.182-8.003-4.89-7.065-0.0350.310.294-1.4910.1650.4920.9878.9789.652.7811.2440.2460.2323.849
Inkomen voor belasting 10.46112.102-6.794-14.667-22.382-31.16-19.026-50.954-61.52-41.52-32.993-52.339-57.086108.178-120.214-143.528-126.82-85.15-49.596-75.472-55.651-58.973
Inkomen voor belasting ratio 0.0660.082-0.046-0.115-0.167-0.235-0.187-0.772-1.165-0.977-0.806-0.897-0.8630.936-4.481-11.986-16.056-11.853-1.626-263.24-146.75-288.593
Belastingkosten 0.01-0.0450.0370.0550.040.1920.3340.3330.0830.0260.0270.6940.560.6140.523-8.978-9.65-2.781-1.244-0.246-0.232-3.849
Nettowinst 10.45112.147-6.831-14.722-22.422-31.352-19.36-51.287-61.603-41.546-33.02-53.033-57.646107.564-120.736-143.528-126.82-85.15-49.596-75.472-55.651-58.973
Nettowinstmarge 0.0660.082-0.046-0.115-0.167-0.237-0.191-0.777-1.166-0.978-0.806-0.909-0.8710.931-4.5-11.986-16.056-11.853-1.626-263.24-146.75-288.593
WPA (Winst Per Aandeel) 0.871.02-0.58-1.43-2.08-2.89-1.79-5.07-6.09-4.17-3.4-5.53-6.0111.19-12.61-15.02-13.97-11.04-6.66-10.86-10.71-11.71
Verwaterde WPA 0.861.02-0.58-1.43-2.08-2.89-1.79-5.07-6.09-4.17-3.4-5.53-6.0111.19-12.61-15.02-13.97-11.04-6.66-10.86-10.71-11.71
EBITDA 22.68219.443.626-20.967-15.561-21.405-12.245-41.67-59.158-39.539-30.571-47.206-54.374111.72-116.248-148.384-124.115-82.184-45.869-71.187-51.131-59.451
EBITDA ratio 0.1440.1320.024-0.164-0.116-0.161-0.121-0.632-1.12-0.93-0.747-0.809-0.8220.967-4.333-12.392-15.714-11.44-1.504-248.295-134.831-290.931